OR WAIT null SECS
- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2021 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Rheumatology Network's Top 5: August 13, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending August 13, 2021.
Leonard Calabrese, DO: Autoimmune Diseases and COVID-19 as Immunology
Leonard Calabrese, DO, discusses his findings entitled, “Applied Immunology to Autoimmune Diseases: COVID-19 as Immunology,” which was presented at the Rheumatology Nurses Society Conference.
Click the image to view the story.
COVID-19 Vaccine Did Not Increase Flares or Adverse Reactions for Patients with Rheumatic Disease
Only 11% of patients reported a flare that required treatment and no participants experienced severe flares. Approximately 60% of flares occurred after D2.
Click the image to view the story.
Brian LaMoreaux, MD, MS: Improving Outcomes for Patients With Gout
Brian LaMoreaux, MD, MS, discusses the recent study entitled, "Improving outcomes for patients hospitalised with gout: a systematic review."
Click the image to view the story.
Alexis Ogdie-Beatty, MD: UPLIFT Survey for Psoriatic Arthritis
Alexis Ogdie-Beatty, MD, discusses the UPLIFT survey and UPLIFT Innovation Challenge, the unmet needs of patients with psoriatic arthritis, and the clinical significance of the survey’s results.
Click the image to view the story.
Comorbidity Burden Increases 3 Years After Diagnosis With Psoriatic Arthritis, Rheumatoid Arthritis
Compared with controls, patients with psoriatic arthritis presented more often with depression at baseline and patients with rheumatoid arthritis had a higher incidence of cardiovascular comorbidity after 3 years.
Click the image to view the story.
Related Content:
